Pub Date : 2026-04-01Epub Date: 2026-01-16DOI: 10.1016/j.jiph.2026.103156
Kexiang Zhang , Ri De , Zeng Li , Yanpeng Xu , Zhenzhi Han , Runan Zhu , Yu Sun , Liping Jia , Dongmei Chen , Yutong Zhou , Qi Guo , Yao Yao , Xiaolin Ma , Shuang Liu , Chunmei Zhu , Dong Qu , Linqing Zhao
Background
Human bocavirus 1 (HBoV1) causes acute respiratory infections (ARIs) in children, but its diagnosis is complicated by prolonged viral shedding. There are indications that the detection of a circular genome in a clinical specimens may be associated with acute infection.
Methods
Respiratory specimens collected from pediatric patients with ARIs during January 2021 to July 2024 were screened by a duplex qPCR, which was developed to distinguish circular genome from total viral genomes and evaluated by nested PCR and antigen test. Clinical data were collected from patients with single HBoV1 infection to reveal the association of circular genome with ARIs and the severity of pneumonia.
Results
Among 520 specimens positive for HBoV1 DNA, 206 (39.61 %) were positive for circular genomes as determined by duplex qPCR, with the median load of total genomes 1010.08 (IQR 109.26, 1010.62) copies/mL significantly higher than 107.81 (IQR 106.88, 108.60) copies/mL in the circular genome negative group (p < 0.0001). In the antigen-positive group, the positive rate for circular genomes was 78.57 % (44/56), significantly higher than 34.29 % (108/315) observed in the antigen-negative group. Among patients single positive for HBoV1, the circular genome-positive group (n = 106) showed more severe clinical manifestations and required more intensive treatment. Logistic regression analysis identified the circular genome as a strong independent risk factor for severe pneumonia (OR = 6.38, AUC = 0.82).
Conclusion
Circular genome of HBoV1 associated with high load of viral DNA, positive antigen and severe pneumonia in children may serve as a biomarker for acute HBoV1 infection and severe pneumonia.
{"title":"Circular genome of human bocavirus 1 associated with high load of viral DNA, positive antigen and increased risk of severe pneumonia in children","authors":"Kexiang Zhang , Ri De , Zeng Li , Yanpeng Xu , Zhenzhi Han , Runan Zhu , Yu Sun , Liping Jia , Dongmei Chen , Yutong Zhou , Qi Guo , Yao Yao , Xiaolin Ma , Shuang Liu , Chunmei Zhu , Dong Qu , Linqing Zhao","doi":"10.1016/j.jiph.2026.103156","DOIUrl":"10.1016/j.jiph.2026.103156","url":null,"abstract":"<div><h3>Background</h3><div>Human bocavirus 1 (HBoV1) causes acute respiratory infections (ARIs) in children, but its diagnosis is complicated by prolonged viral shedding. There are indications that the detection of a circular genome in a clinical specimens may be associated with acute infection.</div></div><div><h3>Methods</h3><div>Respiratory specimens collected from pediatric patients with ARIs during January 2021 to July 2024 were screened by a duplex qPCR, which was developed to distinguish circular genome from total viral genomes and evaluated by nested PCR and antigen test. Clinical data were collected from patients with single HBoV1 infection to reveal the association of circular genome with ARIs and the severity of pneumonia.</div></div><div><h3>Results</h3><div>Among 520 specimens positive for HBoV1 DNA, 206 (39.61 %) were positive for circular genomes as determined by duplex qPCR, with the median load of total genomes 10<sup>10.08</sup> (IQR 10<sup>9.26</sup>, 10<sup>10.62</sup>) copies/mL significantly higher than 10<sup>7.81</sup> (IQR 10<sup>6.88</sup>, 10<sup>8.60</sup>) copies/mL in the circular genome negative group (<em>p</em> < 0.0001). In the antigen-positive group, the positive rate for circular genomes was 78.57 % (44/56), significantly higher than 34.29 % (108/315) observed in the antigen-negative group. Among patients single positive for HBoV1, the circular genome-positive group (n = 106) showed more severe clinical manifestations and required more intensive treatment. Logistic regression analysis identified the circular genome as a strong independent risk factor for severe pneumonia (OR = 6.38, AUC = 0.82).</div></div><div><h3>Conclusion</h3><div>Circular genome of HBoV1 associated with high load of viral DNA, positive antigen and severe pneumonia in children may serve as a biomarker for acute HBoV1 infection and severe pneumonia.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103156"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2026-01-08DOI: 10.1016/j.jiph.2026.103141
Shital Ghogale, Ketaki Pathak
{"title":"Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A call for global surveillance and coordinated action","authors":"Shital Ghogale, Ketaki Pathak","doi":"10.1016/j.jiph.2026.103141","DOIUrl":"10.1016/j.jiph.2026.103141","url":null,"abstract":"","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103141"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146125319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2026-02-26DOI: 10.1016/j.jiph.2026.103187
Greta Petazzoni , Stefano Gaiarsa , Irene Mileto , Angela Kuka , Marta Corbella , Cristina Merla , Antonio Piralla , Marina Ramus , Aurora Piazza , Vittoria Mattioni Marchetti , Roberta Migliavacca , Alba Muzzi , Patrizia Cambieri , Fausto Baldanti
Background
Healthcare-associated infections (HAIs) in Europe affect millions of patients annually, driving antimicrobial resistance and imposing significant economic burdens. Carbapenem-resistant Enterobacterales (CRE) are particularly concerning due to their ability to spread, making genomic surveillance essential for tracking their transmission.
Methods
From October 2022 to September 2023, we sequenced and analysed the genome of 340 CRE obtained from patients admitted to Fondazione IRCCS Policlinico San Matteo ( Italy). Sequencing was performed using a short-read approach and genomes were in-silico characterized to identify Sequence Types (STs), antimicrobial resistance and virulence determinants, and plasmid content. Moreover, a core SNP-based phylogeny was performed to identify potential epidemic clusters within the same clone.
Results
Among the 340 CRE isolated from surveillance (N = 234) and other clinical specimens (N = 106), 87.7% belonged to the Klebsiella genus, primarily K. pneumoniae (CR-Kp, N = 284). Escherichia coli (CR-Ec) accounted for 8.5% (N = 29); while the remaining species were Enterobacter spp. (N = 13) and Citrobacter spp. (N = 9). blaKPC and blaNDM gene variants were detected in 55.9% and 25.6% of CRE, respectively. The most prevalent CR-Kp clones were ST307, ST6668, ST258, and ST512, whereas ST131 was dominant among CR-Ec. Large epidemic clusters (ECs; ≥ 5 strains in each clade) were mainly found in CR-Kp associated with ST307 and ST6668, with 80.63% of CR-Kp grouped into nine ECs. Conversely, other species were observed as sporadic cases or within transmission clusters with limited spread.
Conclusion
Our comprehensive analysis of CRE circulation at HSM revealed that their dissemination was largely driven by highly successful clones, shedding light on several of them.
背景:欧洲医疗保健相关感染(HAIs)每年影响数百万患者,推动抗菌素耐药性并造成重大经济负担。碳青霉烯耐药肠杆菌(CRE)由于其传播能力特别令人担忧,因此基因组监测对于跟踪其传播至关重要。方法:从2022年10月至2023年9月,我们对来自意大利圣马泰奥基金会(Fondazione IRCCS Policlinico San Matteo)收治的340例CRE患者的基因组进行了测序和分析。测序采用短读法,并对基因组进行了计算机表征,以确定序列类型(STs)、抗菌素耐药性和毒力决定因素以及质粒含量。此外,还进行了基于核心snp的系统发育,以确定同一克隆中潜在的流行病聚集性。结果:监测分离到的340株CRE (N = 234)和其他临床标本(N = 106)中,克雷伯氏菌属占87.7%,以肺炎克雷伯氏菌(CR-Kp, N = 284)为主。大肠杆菌(CR-Ec)占8.5% (N = 29);其余菌种为肠杆菌(N = 13)和柠檬酸杆菌(N = 9)。在CRE中分别检测到55.9%和25.6%的blaKPC和blaNDM基因变异。CR-Kp无性系以ST307、ST6668、ST258和ST512最为普遍,而CR-Ec无性系以ST131为主。与ST307和ST6668相关的CR-Kp主要存在大流行聚集性(ECs,每个进化支≥5株),其中80.63%的CR-Kp归为9个ECs。相反,其他物种为散发病例或传播聚集性病例,传播有限。结论:我们对HSM的CRE循环进行了综合分析,发现它们的传播主要是由非常成功的克隆驱动的,从而揭示了其中一些克隆。
{"title":"Empowering active surveillance of Carbapenem-resistant Enterobacterales: Insights from one year of genomic surveillance","authors":"Greta Petazzoni , Stefano Gaiarsa , Irene Mileto , Angela Kuka , Marta Corbella , Cristina Merla , Antonio Piralla , Marina Ramus , Aurora Piazza , Vittoria Mattioni Marchetti , Roberta Migliavacca , Alba Muzzi , Patrizia Cambieri , Fausto Baldanti","doi":"10.1016/j.jiph.2026.103187","DOIUrl":"10.1016/j.jiph.2026.103187","url":null,"abstract":"<div><h3>Background</h3><div>Healthcare-associated infections (HAIs) in Europe affect millions of patients annually, driving antimicrobial resistance and imposing significant economic burdens. Carbapenem-resistant <em>Enterobacterales</em> (CRE) are particularly concerning due to their ability to spread, making genomic surveillance essential for tracking their transmission.</div></div><div><h3>Methods</h3><div>From October 2022 to September 2023, we sequenced and analysed the genome of 340 CRE obtained from patients admitted to Fondazione IRCCS Policlinico San Matteo ( Italy). Sequencing was performed using a short-read approach and genomes were <em>in-silico</em> characterized to identify Sequence Types (STs), antimicrobial resistance and virulence determinants, and plasmid content. Moreover, a core SNP-based phylogeny was performed to identify potential epidemic clusters within the same clone.</div></div><div><h3>Results</h3><div>Among the 340 CRE isolated from surveillance (N = 234) and other clinical specimens (N = 106), 87.7% belonged to the <em>Klebsiella</em> genus, primarily <em>K. pneumoniae</em> (CR-Kp, N = 284). <em>Escherichia coli</em> (CR-Ec) accounted for 8.5% (N = 29); while the remaining species were <em>Enterobacter spp.</em> (N = 13) and <em>Citrobacter spp.</em> (N = 9). <em>bla</em><sub>KPC</sub> and <em>bla</em><sub>NDM</sub> gene variants were detected in 55.9% and 25.6% of CRE, respectively. The most prevalent CR-Kp clones were ST307, ST6668, ST258, and ST512, whereas ST131 was dominant among CR-Ec. Large epidemic clusters (ECs; ≥ 5 strains in each clade) were mainly found in CR-Kp associated with ST307 and ST6668, with 80.63% of CR-Kp grouped into nine ECs. Conversely, other species were observed as sporadic cases or within transmission clusters with limited spread.</div></div><div><h3>Conclusion</h3><div>Our comprehensive analysis of CRE circulation at HSM revealed that their dissemination was largely driven by highly successful clones, shedding light on several of them.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103187"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147355209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2026-01-31DOI: 10.1016/j.jiph.2026.103161
Zhenchao Wu , Yanqiu Ma , Jiajia Zheng , Ping Yang , Ming Lu , Du Yipeng , Ning Shen
Background
Ceftazidime/avibactam (CZA) resistance (CZAr) poses critical challenges for the treatment of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. The early identification of high-risk populations is essential for controlling nosocomial transmission and guiding empirical therapy. This study aimed to systematically focus on the correlation between the clinical characteristics of patients and the microbial features of CZArCRKP.
Methods
We conducted a retrospective cohort study (January 2020-May 2023) of 97 patients with CRKP infection. Antimicrobial susceptibility testing and whole-genome sequencing (WGS) were used to analyze resistance phenotype-genotype correlations. Survival outcomes were evaluated using Kaplan–Meier analysis.
Results
CZArCRKP primarily caused lower respiratory (72.16 %) and urinary tract (16.49 %) infections, predominantly affecting elderly patients with comorbidities (81.4 %) or undergoing invasive procedures (63.9 %). Chronic renal failure combined with platelet counts > 149× 10⁹/L post-infection strongly predicted patients with CZArCRKP in pulmonary infections. NDM-1 gene carriage and OmpK36 mutations were associated with CZA resistance. CZA-treated patients demonstrated lower 14-day mortality rates.
Conclusion
We established the first integrated host-pathogen risk model for CZArCRKP and identified chronic renal failure and platelet count as key clinical predictors. NDM-1/OmpK36 mutations represents a clear mechanism of resistance. CZA use may improve the survival of selected patients with CRKP. These findings advance the surveillance and therapeutic strategies for multidrug-resistant infections.
{"title":"Risk factors, clinical outcomes of patients with Ceftazidime/Avibactam-resistant carbapenem-Resistant Klebsiella pneumoniae infection and its potential resistant mechanisms","authors":"Zhenchao Wu , Yanqiu Ma , Jiajia Zheng , Ping Yang , Ming Lu , Du Yipeng , Ning Shen","doi":"10.1016/j.jiph.2026.103161","DOIUrl":"10.1016/j.jiph.2026.103161","url":null,"abstract":"<div><h3>Background</h3><div>Ceftazidime/avibactam (CZA) resistance (CZAr) poses critical challenges for the treatment of carbapenem-resistant <em>Klebsiella pneumoniae</em> (CRKP) infections. The early identification of high-risk populations is essential for controlling nosocomial transmission and guiding empirical therapy. This study aimed to systematically focus on the correlation between the clinical characteristics of patients and the microbial features of CZArCRKP.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study (January 2020-May 2023) of 97 patients with CRKP infection. Antimicrobial susceptibility testing and whole-genome sequencing (WGS) were used to analyze resistance phenotype-genotype correlations. Survival outcomes were evaluated using Kaplan–Meier analysis.</div></div><div><h3>Results</h3><div>CZArCRKP primarily caused lower respiratory (72.16 %) and urinary tract (16.49 %) infections, predominantly affecting elderly patients with comorbidities (81.4 %) or undergoing invasive procedures (63.9 %). Chronic renal failure combined with platelet counts > 149× 10⁹/L post-infection strongly predicted patients with CZArCRKP in pulmonary infections. <em>NDM-1</em> gene carriage and <em>OmpK36</em> mutations were associated with CZA resistance. CZA-treated patients demonstrated lower 14-day mortality rates.</div></div><div><h3>Conclusion</h3><div>We established the first integrated host-pathogen risk model for CZArCRKP and identified chronic renal failure and platelet count as key clinical predictors. <em>NDM-1/OmpK36</em> mutations represents a clear mechanism of resistance. CZA use may improve the survival of selected patients with CRKP. These findings advance the surveillance and therapeutic strategies for multidrug-resistant infections.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103161"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2025-12-27DOI: 10.1016/j.jiph.2025.103122
{"title":"Calls for papers: Antimicrobial resistance and one health: interdisciplinary strategies to address a global challenge – Virtual special issue","authors":"","doi":"10.1016/j.jiph.2025.103122","DOIUrl":"10.1016/j.jiph.2025.103122","url":null,"abstract":"","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103122"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146172262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The World Health Organization roadmap targets the eradication of dengue, a neglected tropical disease. Community participation is crucial for successful control efforts, which must transcend technical solutions to engage and motivate the public. This study examined the needs, perceptions, and emotional drivers underpinning dengue prevention efforts and recommended tailored policies to control dengue in varied settings.
Methods
This mixed-methods study, using a triangulation design, was conducted in four geographical regions of Thailand between November 2023 and April 2024. Quantitative surveys were administered to 664 community members and 430 public health personnel, complemented by 10 focus group discussions (FGDs) with community members, 16 FGDs, and 23 in-depth interviews (IDIs) with public health personnel. Logistic regression was used to examine factors associated with dengue control practices, while qualitative data were analyzed thematically. Findings from both components were integrated during interpretation to enhance the robustness of conclusions.
Results
Integrated quantitative and qualitative findings showed that most participants practiced active dengue prevention. Social support strongly influenced preventive behaviors (OR 19.81; 95 % CI 8.53–46.03), whereas demographic factors and perceived susceptibility or severity were not significant. Higher practice levels were observed among participants in the northeast and health personnel aged ≥ 50 years. Qualitative data reinforced these findings, emphasizing the vital role of village health volunteers and challenges such as limited participation, low risk perception, poor sanitation, and cultural barriers shaping vaccine hesitancy.
Conclusion
Effective dengue control requires context-specific, evidence-based strategies that strengthen community participation, empower village health volunteers, and enhance vector control. Early warning systems and intersectoral collaboration are vital in high-risk areas, while transparent, culturally tailored communication can improve vaccine acceptance. These findings provide evidence to guide policy toward sustainable, community-centered dengue prevention and control.
背景:世界卫生组织路线图的目标是消灭登革热,这是一种被忽视的热带病。社区参与对于成功的控制工作至关重要,必须超越技术解决方案,让公众参与并激励公众。这项研究调查了登革热预防工作的需求、观念和情感驱动因素,并建议了在不同环境下控制登革热的有针对性的政策。方法:该混合方法研究于2023年11月至2024年4月在泰国的四个地理区域进行,采用三角测量设计。对664名社区成员和430名公共卫生人员进行了定量调查,并与社区成员进行了10次焦点小组讨论(fgd), 16次焦点小组讨论(fgd), 23次与公共卫生人员进行了深入访谈(IDIs)。使用逻辑回归来检查与登革热控制措施相关的因素,同时对定性数据进行主题分析。在解释过程中整合了两个组成部分的发现,以增强结论的稳健性。结果:综合定量和定性研究结果显示,大多数参与者都采取了积极的登革热预防措施。社会支持强烈影响预防行为(OR 19.81; 95 % CI 8.53-46.03),而人口因素和感知易感性或严重程度不显著。在东北地区的参与者和年龄≥ 50岁的卫生人员中观察到较高的实践水平。定性数据强化了这些发现,强调了乡村卫生志愿者的重要作用和挑战,如参与有限、风险认知低、卫生条件差以及形成疫苗犹豫的文化障碍。结论:有效的登革热控制需要针对具体情况的循证战略,加强社区参与,赋予乡村卫生志愿者权力,并加强媒介控制。预警系统和部门间合作在高风险地区至关重要,而透明的、有文化针对性的沟通可以提高疫苗的接受度。这些发现为指导可持续、以社区为中心的登革热预防和控制政策提供了证据。
{"title":"Community-driven policy recommendations for dengue prevention and control in Thailand: A mixed-methods study","authors":"Chawarat Rotejanaprasert , Ngamphol Soonthornworasiri , Lokachet Tanasugarn , Amorn Leelarasamee , Kulkanya Chokephaibulkit , Udomsak Narkkul , Peeradone Srichan , Khuanchai Koompapong , Piroon Mootsikapun , Winai Ratanasuwan , Saranath Lawpoolsri","doi":"10.1016/j.jiph.2026.103166","DOIUrl":"10.1016/j.jiph.2026.103166","url":null,"abstract":"<div><h3>Background</h3><div>The World Health Organization roadmap targets the eradication of dengue, a neglected tropical disease. Community participation is crucial for successful control efforts, which must transcend technical solutions to engage and motivate the public. This study examined the needs, perceptions, and emotional drivers underpinning dengue prevention efforts and recommended tailored policies to control dengue in varied settings.</div></div><div><h3>Methods</h3><div>This mixed-methods study, using a triangulation design, was conducted in four geographical regions of Thailand between November 2023 and April 2024. Quantitative surveys were administered to 664 community members and 430 public health personnel, complemented by 10 focus group discussions (FGDs) with community members, 16 FGDs, and 23 in-depth interviews (IDIs) with public health personnel. Logistic regression was used to examine factors associated with dengue control practices, while qualitative data were analyzed thematically. Findings from both components were integrated during interpretation to enhance the robustness of conclusions.</div></div><div><h3>Results</h3><div>Integrated quantitative and qualitative findings showed that most participants practiced active dengue prevention. Social support strongly influenced preventive behaviors (OR 19.81; 95 % CI 8.53–46.03), whereas demographic factors and perceived susceptibility or severity were not significant. Higher practice levels were observed among participants in the northeast and health personnel aged ≥ 50 years. Qualitative data reinforced these findings, emphasizing the vital role of village health volunteers and challenges such as limited participation, low risk perception, poor sanitation, and cultural barriers shaping vaccine hesitancy.</div></div><div><h3>Conclusion</h3><div>Effective dengue control requires context-specific, evidence-based strategies that strengthen community participation, empower village health volunteers, and enhance vector control. Early warning systems and intersectoral collaboration are vital in high-risk areas, while transparent, culturally tailored communication can improve vaccine acceptance. These findings provide evidence to guide policy toward sustainable, community-centered dengue prevention and control.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103166"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2026-02-10DOI: 10.1016/j.jiph.2026.103181
Chong-Wei Huang , Wei-Chao Liao , Ian Yi-Feng Chang , En-Wei Hsing , Chung-Guei Huang , Jainn-Jim Lin , Kuang-Lin Lin , Cheng-Hsun Chiu , Chih-Ho Chen , Jen-Han Chen , Wen-I Lee , Yu-Chia Hsieh
Background
The Omicron variant of SARS-CoV-2 has caused severe complications in children, including encephalitis/encephalopathy and croup, yet the underlying pathogenic mechanisms remain unclear. Transcriptome analysis could provide insights into immune responses and guide clinical management strategies.
Methods
We conducted a case-control cohort study of COVID-19 patients across two medical centers in Taiwan from April 17 to November 7, 2022. Blood RNA sequencing was used to analyze differences in gene expression and functional pathways between cases of encephalitis/encephalopathy or croup of varying severity and controls with mild febrile disease. We applied computational analyses to identify transcriptomic signatures linked to COVID-19 associated encephalitis/encephalopathy.
Results
This study included 61 patients diagnosed with SARS-CoV-2 infection: 29 with mild febrile disease, 14 with croup, and 18 with encephalitis/encephalopathy. More differentially expressed genes were identified in encephalitis/encephalopathy (n = 834) than in croup (n = 185). Functional enrichment analysis revealed coordinated upregulation of myeloid leukocyte, neutrophil, and macrophage pathways in encephalitis/encephalopathy, accompanied by downregulation of HLA class II expression, antigen presentation, and T-cell activation, with changes tracking disease severity. CIBERSORT analysis revealed increased activated dendritic cells and reduced naïve CD4 T cells, CD8 T cells, naïve B cells, and NK cells. Croup patients showed reduced antigen presentation and low T cell receptor signaling. Gene expression profiles differentiated encephalitis/encephalopathy from mild febrile disease with a positive predictive value of 95.3 %.
Conclusion
Future interventions aiming at innate immune dysregulation, such as neutrophil inhibition, addressing macrophage activation, and enhancing T-cell responses, could play a promising role in improving outcomes for children infected with emerging, virulent SARS-CoV-2 variants.
{"title":"Whole blood gene expression to assess disease severity of omicron-associated acute encephalitis and croup in children: A transcriptomic and immune profiling study","authors":"Chong-Wei Huang , Wei-Chao Liao , Ian Yi-Feng Chang , En-Wei Hsing , Chung-Guei Huang , Jainn-Jim Lin , Kuang-Lin Lin , Cheng-Hsun Chiu , Chih-Ho Chen , Jen-Han Chen , Wen-I Lee , Yu-Chia Hsieh","doi":"10.1016/j.jiph.2026.103181","DOIUrl":"10.1016/j.jiph.2026.103181","url":null,"abstract":"<div><h3>Background</h3><div>The Omicron variant of SARS-CoV-2 has caused severe complications in children, including encephalitis/encephalopathy and croup, yet the underlying pathogenic mechanisms remain unclear. Transcriptome analysis could provide insights into immune responses and guide clinical management strategies.</div></div><div><h3>Methods</h3><div>We conducted a case-control cohort study of COVID-19 patients across two medical centers in Taiwan from April 17 to November 7, 2022. Blood RNA sequencing was used to analyze differences in gene expression and functional pathways between cases of encephalitis/encephalopathy or croup of varying severity and controls with mild febrile disease. We applied computational analyses to identify transcriptomic signatures linked to COVID-19 associated encephalitis/encephalopathy.</div></div><div><h3>Results</h3><div>This study included 61 patients diagnosed with SARS-CoV-2 infection: 29 with mild febrile disease, 14 with croup, and 18 with encephalitis/encephalopathy. More differentially expressed genes were identified in encephalitis/encephalopathy (n = 834) than in croup (n = 185). Functional enrichment analysis revealed coordinated upregulation of myeloid leukocyte, neutrophil, and macrophage pathways in encephalitis/encephalopathy, accompanied by downregulation of HLA class II expression, antigen presentation, and T-cell activation, with changes tracking disease severity. CIBERSORT analysis revealed increased activated dendritic cells and reduced naïve CD4 T cells, CD8 T cells, naïve B cells, and NK cells. Croup patients showed reduced antigen presentation and low T cell receptor signaling. Gene expression profiles differentiated encephalitis/encephalopathy from mild febrile disease with a positive predictive value of 95.3 %.</div></div><div><h3>Conclusion</h3><div>Future interventions aiming at innate immune dysregulation, such as neutrophil inhibition, addressing macrophage activation, and enhancing T-cell responses, could play a promising role in improving outcomes for children infected with emerging, virulent SARS-CoV-2 variants.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103181"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2026-02-12DOI: 10.1016/j.jiph.2026.103183
Raghav Krishnan Kulandaivelu , Aditi Roy , Soham Roy , J.S. Amith Velavan , Reddysai Amudala , Debraj Joel Das Adhikari , Karan S.V. , Sudha Ramaiah , Anand Anbarasu
Eye infections are a significant area of microbial adaptation and therapeutic challenge, as antibiotic resistance threatens vision. In the last ten years, our knowledge of the ocular resistome has expanded through genomics and molecular epidemiology. An analysis of global evidence from 2015 to 2025 on the resistance architecture of major ocular pathogens will be presented, with a focus on Pseudomonas aeruginosa (P. aeruginosa). The organism shows remarkable genomic flexibility by incorporating intrinsic resistance elements, biofilm-mediated tolerance, and by acquiring ARGs such as blaVIM, blaGES, QnrVC and RmtB by horizontal transfer. According to researchers, Staphylococcus aureus (S. aureus), Streptococcus pneumoniae (S. pneumoniae), and Acinetobacter baumannii (A. baumannii) have evolved mechanisms of drug resistance. Geographic analysis shows regional disparities, particularly in South Asia and North America, which are associated with antibiotic use and clinical exposure. To prevent the emergence of ocular antimicrobial resistance, there’s an urgent need for rapid molecular diagnostics, genomic-based surveillance, and responsible antimicrobial stewardship.
{"title":"A comprehensive review of resistome profiles in ocular pathogens: Insights into Pseudomonas aeruginosa and emerging resistance trends","authors":"Raghav Krishnan Kulandaivelu , Aditi Roy , Soham Roy , J.S. Amith Velavan , Reddysai Amudala , Debraj Joel Das Adhikari , Karan S.V. , Sudha Ramaiah , Anand Anbarasu","doi":"10.1016/j.jiph.2026.103183","DOIUrl":"10.1016/j.jiph.2026.103183","url":null,"abstract":"<div><div>Eye infections are a significant area of microbial adaptation and therapeutic challenge, as antibiotic resistance threatens vision. In the last ten years, our knowledge of the ocular resistome has expanded through genomics and molecular epidemiology. An analysis of global evidence from 2015 to 2025 on the resistance architecture of major ocular pathogens will be presented, with a focus on <em>Pseudomonas aeruginosa</em> (<em>P. aeruginosa)</em>. The organism shows remarkable genomic flexibility by incorporating intrinsic resistance elements, biofilm-mediated tolerance, and by acquiring ARGs such as <em>bla</em><sub>VIM</sub>, <em>bla</em><sub>GES</sub>, QnrVC and RmtB by horizontal transfer. According to researchers, <em>Staphylococcus aureus</em> (<em>S. aureus</em>)<em>, Streptococcus pneumoniae</em> (<em>S. pneumoniae)</em>, and <em>Acinetobacter baumannii (A. baumannii)</em> have evolved mechanisms of drug resistance. Geographic analysis shows regional disparities, particularly in South Asia and North America, which are associated with antibiotic use and clinical exposure. To prevent the emergence of ocular antimicrobial resistance, there’s an urgent need for rapid molecular diagnostics, genomic-based surveillance, and responsible antimicrobial stewardship.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103183"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2026-01-15DOI: 10.1016/j.jiph.2026.103153
Seyed Hassan Saadat , Behzad Einollahi , Hadi Norouzi , Mohammad Farjami , Nematollah Jonaidi Jafari , Shahla Afsharpeyman , Fahime Shahjooie , Ali Bahrami Far , Kiavash Hushmandi
Background
Lactate dehydrogenase (LDH) has emerged as a potential biomarker for COVID-19 severity, but the diagnostic value of its dynamic changes (ΔLDH) remains unclear. This study aimed to determine the predictive value of ΔLDH for clinical outcomes in hospitalized patients with COVID-19.
Methods
We performed a retrospective cohort study of 5635 adults with confirmed COVID-19, analyzing LDH measurements. The patients were stratified by ΔLDH quartiles (Q1-Q4). Multivariable logistic regression was used to assess the associations with mortality and ICU admission, while ROC analysis was used to determine the predictive performance.
Results
A U-shaped relationship was observed, with both extreme reductions (Q1: ΔLDH ≤ -196 U/L) and elevations (Q4: ΔLDH ≥ 108 U/L) predicting adverse outcomes. Q4 patients had a higher risk of mortality (aOR = 6.72, 95 % CI: 5.31–8.51) and a higher risk of ICU admission (aOR = 6.63, 95 % CI: 5.26–8.36) compared to Q1. ΔLDH revealed excellent discrimination for mortality (AUC = 0.78) with an optimal cutoff at 181.5 U/L (sensitivity = 66.7 %, specificity = 88.9 %).
Conclusion
ΔLDH is a powerful, independent predictor of COVID-19 severity, revealing a novel U-shaped risk pattern. The 181.5 U/L threshold offers clinically actionable guidance for risk stratification. These findings support the incorporation of serial LDH monitoring into COVID-19 management protocols.
{"title":"The role of changes in lactate dehydrogenase (LDH) levels in predicting COVID-19 severity and mortality: A biomarker analysis","authors":"Seyed Hassan Saadat , Behzad Einollahi , Hadi Norouzi , Mohammad Farjami , Nematollah Jonaidi Jafari , Shahla Afsharpeyman , Fahime Shahjooie , Ali Bahrami Far , Kiavash Hushmandi","doi":"10.1016/j.jiph.2026.103153","DOIUrl":"10.1016/j.jiph.2026.103153","url":null,"abstract":"<div><h3>Background</h3><div>Lactate dehydrogenase (LDH) has emerged as a potential biomarker for COVID-19 severity, but the diagnostic value of its dynamic changes (ΔLDH) remains unclear. This study aimed to determine the predictive value of ΔLDH for clinical outcomes in hospitalized patients with COVID-19.</div></div><div><h3>Methods</h3><div>We performed a retrospective cohort study of 5635 adults with confirmed COVID-19, analyzing LDH measurements. The patients were stratified by ΔLDH quartiles (Q1-Q4). Multivariable logistic regression was used to assess the associations with mortality and ICU admission, while ROC analysis was used to determine the predictive performance.</div></div><div><h3>Results</h3><div>A U-shaped relationship was observed, with both extreme reductions (Q1: ΔLDH ≤ -196 U/L) and elevations (Q4: ΔLDH ≥ 108 U/L) predicting adverse outcomes. Q4 patients had a higher risk of mortality (aOR = 6.72, 95 % CI: 5.31–8.51) and a higher risk of ICU admission (aOR = 6.63, 95 % CI: 5.26–8.36) compared to Q1. ΔLDH revealed excellent discrimination for mortality (AUC = 0.78) with an optimal cutoff at 181.5 U/L (sensitivity = 66.7 %, specificity = 88.9 %).</div></div><div><h3>Conclusion</h3><div>ΔLDH is a powerful, independent predictor of COVID-19 severity, revealing a novel U-shaped risk pattern. The 181.5 U/L threshold offers clinically actionable guidance for risk stratification. These findings support the incorporation of serial LDH monitoring into COVID-19 management protocols.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103153"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Household transmission of SARS-CoV-2 remains a key driver of community spread, with secondary attack rates in Thai households reaching approximately 50 %. There is limited evidence supporting the efficacy of antiviral post-exposure prophylaxis (PEP) in this context.
Methods
The phase 2/3, open-label, (1:1) cluster-randomized controlled trial in Thailand, 168 household close contacts from 76 index cases were enrolled to receive either favipiravir-PEP (FPV-PEP) (1600–2000 mg/day for 7 days) or usual care. The efficacy of FPV-PEP was investigated in preventing SARS-CoV-2 infection after contact with index cases.
Results
The incidence of confirmed SARS-CoV-2 infection was lower in the FPV-PEP group than in the usual care group (7.32 % vs. 14.47 %), although the difference was not statistically significant. A trend toward fewer early positive rapid diagnostic test results on day 3 was observed in the FPV-PEP group. Symptom development was less frequent among FPV-PEP recipients, with fewer cases of fever, rhinorrhea, and myalgia. A significantly higher probability of remaining asymptomatic and delayed symptom onset was observed in the FPV-PEP group. No participants developed severe COVID-19 or required hospitalization.
Conclusion
FPV-PEP was associated with a lower incidence of fever, rhinorrhea, and myalgia among household contacts. While a reduction in secondary transmission was observed, it did not reach statistical significance. Further large-scale studies are warranted to clarify its role in preventing household transmission.
{"title":"Post-exposure prophylaxis with favipiravir among household close contacts to confirmed COVID-19 cases: A cluster-randomized trial (PEPfavi)","authors":"Taweegrit Siripongboonsitti , Teerapat Ungtrakul , Kriangkrai Tawinprai , Krongkwan Niemsorn , Kunsuda Punjachaipornpol , Worrawat Sangwipasnapaporn , Natcha Wattanapokasilp , Marisa Muadchimkaew , Saowanee Wongpatcharawarakul , Kamonwan Soonklang , Nithi Mahanonda","doi":"10.1016/j.jiph.2026.103150","DOIUrl":"10.1016/j.jiph.2026.103150","url":null,"abstract":"<div><h3>Background</h3><div>Household transmission of SARS-CoV-2 remains a key driver of community spread, with secondary attack rates in Thai households reaching approximately 50 %. There is limited evidence supporting the efficacy of antiviral post-exposure prophylaxis (PEP) in this context.</div></div><div><h3>Methods</h3><div>The phase 2/3, open-label, (1:1) cluster-randomized controlled trial in Thailand, 168 household close contacts from 76 index cases were enrolled to receive either favipiravir-PEP (FPV-PEP) (1600–2000 mg/day for 7 days) or usual care. The efficacy of FPV-PEP was investigated in preventing SARS-CoV-2 infection after contact with index cases.</div></div><div><h3>Results</h3><div>The incidence of confirmed SARS-CoV-2 infection was lower in the FPV-PEP group than in the usual care group (7.32 % vs. 14.47 %), although the difference was not statistically significant. A trend toward fewer early positive rapid diagnostic test results on day 3 was observed in the FPV-PEP group. Symptom development was less frequent among FPV-PEP recipients, with fewer cases of fever, rhinorrhea, and myalgia. A significantly higher probability of remaining asymptomatic and delayed symptom onset was observed in the FPV-PEP group. No participants developed severe COVID-19 or required hospitalization.</div></div><div><h3>Conclusion</h3><div>FPV-PEP was associated with a lower incidence of fever, rhinorrhea, and myalgia among household contacts. While a reduction in secondary transmission was observed, it did not reach statistical significance. Further large-scale studies are warranted to clarify its role in preventing household transmission.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103150"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}